Globus Medical Inc  

(Public, NYSE:GMED)   Watch this stock  
Find more results for GMED
-0.59 (-2.47%)
May 1 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 23.15 - 24.35
52 week 17.45 - 26.07
Open 23.93
Vol / Avg. 0.00/516,004.00
Mkt cap 2.21B
P/E 24.11
Div/yield     -
EPS 0.97
Shares 70.83M
Beta     -
Inst. own 89%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 21.46% 19.50%
Operating margin 30.78% 29.17%
EBITD margin - 34.95%
Return on average assets 16.42% 14.57%
Return on average equity 19.46% 17.49%
Employees 900 -
CDP Score - -


2560 General Armistead Ave
AUDUBON, PA 19403-5214
United States - Map
+1-610-9301800 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Globus Medical, Inc. (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company's products fall into one of two categories: Innovative Fusion or Disruptive Technologies. The Company sells its products through exclusive sales force in the United States, as well as within North, Central & South America, Europe, Asia, Africa and Australia. The sales force consists of direct sales representatives and distributor sales representatives employed by exclusive independent distributors.

Officers and directors

David C. Paul Chairman of the Board, Chief Executive Officer
Age: 47
David M. Demski President, Chief Operating Officer, Director
Age: 56
A. Brett Murphy Executive Vice President, US Sales
Age: 49
David D. Davidar Senior Vice President - Operations , Director
Age: 48
Steven M. Payne Chief Accounting Officer
Age: 43
Daniel T. Lemaitre Independent Director
Age: 60
Robert W. Liptak CPA Independent Director
Ann D. Rhoads Independent Director
Age: 49
Kurt C. Wheeler Independent Director